Willem Mario Kuhtreiber, Ph.D.
This page shows the publications Willem Kuhtreiber has written about Receptors, Tumor Necrosis Factor, Type II.
TNFR2 blockade alone or in combination with PD-1 blockade shows therapeutic efficacy in murine cancer models. J Leukoc Biol. 2020 06; 107(6):981-991.
Optimizing TNFR2 antagonism for immunotherapy with tumor microenvironment specificity. J Leukoc Biol. 2020 06; 107(6):971-980.
Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism. Proc Natl Acad Sci U S A. 2008 Sep 09; 105(36):13644-9.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.